2Chinese Thoracic Society of Chinese Medical Association. Guideling on diagnosis and treatment of community acquired pneumonia(draft).Chin J Tubere Respir Dis,1999,22:199-201.中华医学会呼吸病学分会. 社区获得性肺炎诊断和治
3Watanabe Y, Hatano K, Matsumoto Y,et al. In vitro antibacterial activity of FK041, a new orally active cephalosporin. J Antibiot, 1999, 52: 649-659.
4Wise R, Andrewsj M, Thornber D. The in vitro activity of cefdinir (FK482),a new oral cephalosporin [J].J Antimicrob Chemother, 1991, 28:239-248.
5Lee CS, Ryu EJ, Oh SH, et al.Synthesis and antibacterial activites of novel C (3)-aminopyrimidinyl substituted cephalosporin including against respiratory tract pathogens. Bioorg Med Chem Lett, 2000, 10: 2123-2127.
6Sultan T, Baltch AL, Smith RP, et al. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolabed from adult and pediatric patients. Chemotherapy, 1994, 40: 80-91.
7Block SL, Hedrick JA, Kratzer J, et al. Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy. Pediatr infect Dis J, 2000, 19(12 suppl): SI53-SI58.
8Tack KJ, Keyserling CH, Mccarty J, et al. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. Antimicrob Agents Chemother, 1997, 41: 739-742.
9Pichicheco ME, Gooch WM. Comparion of cefdinir and pencillin V in the treatment of pediatric streptococcal tonsillopharyngitis. Pediatr Infect Dis J, 2000, 19(12 suppl): SI71-SI73.
10Drehobl M, Bianchi P, Keyserling CH, et al. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia. Antimicrob Agents Chemother, 1997, 41: 1579-1583.
